Hospital
Hospital Service District No 1-A of the Parish of Richland State of LA
Hospital Service District No 1-A of the Parish of Richland State of LA was paid $5.07M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 30% of everything it billed.
33Billing provider infoHOSPITAL SERVICE DISTRICT NO 1-A OF THE PARISH OF RICHLAND STATE OF LA
DELHI, LA 71232
DELHI, LA 71232
33aNPI1336109768assigned 03/28/2006
33bProvider typeCritical Access Hospital
28Total paid$5.07M
24GClaims111,712
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Louisiana
Rank by total paid#13 of 40
Median peer was paid$3.19M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,842 | $360K | |
| 2019 | 15,843 | $299K | |
| 2020 | 10,797 | $352K | |
| 2021 | 16,140 | $953K | |
| 2022 | 19,094 | $1.29M | |
| 2023 | 19,629 | $1.11M | |
| 2024incomplete | 15,367 | $713K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 30% | 4,258 | 3,898 | $1.52M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 4,236 | 3,575 | $1.28M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 3,367 | 2,928 | $626K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.8% | 832 | 676 | $346K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 5.0% | 177 | 156 | $252K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.4% | 423 | 352 | $121K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 1,305 | 1,092 | $83K |
| 80061 | Lipid panel | 1.5% | 6,454 | 5,992 | $75K |
| 80053 | Comprehensive metabolic panel | 1.2% | 7,774 | 6,881 | $60K |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,977 | 19,609 | $50K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,165 | 4,722 | $42K |
| 80050 | General health panel | <1% | 965 | 898 | $41K |
67 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,673 | $40K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,033 | $39K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,185 | $38K |
| 83880 | <1% | 1,503 | $34K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 566 | $32K |
| 71045 | Radiologic examination, chest; single view | <1% | 534 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,425 | $30K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $26K |
| 87581 | <1% | 944 | $25K | |
| 87486 | <1% | 949 | $25K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,015 | $23K |
| 83735 | <1% | 3,457 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 991 | $14K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 29 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,871 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 421 | $13K |
| 85027 | <1% | 2,315 | $12K | |
| 70210 | <1% | 219 | $12K | |
| 81001 | <1% | 4,564 | $11K | |
| 80164 | <1% | 857 | $10K | |
| 80305 | <1% | 1,095 | $10K | |
| 95800 | <1% | 17 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 182 | $9K |
| 84484 | <1% | 1,257 | $9K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 79 | $8K |
| 83605 | <1% | 975 | $7K | |
| 82553 | <1% | 1,251 | $7K | |
| 82607 | <1% | 550 | $7K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 47 | $6K |
| 82746 | <1% | 451 | $5K | |
| 82550 | <1% | 1,273 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 355 | $5K |
| 82728 | <1% | 172 | $2K | |
| 81025 | <1% | 232 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 13 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 17 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 41 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 41 | $1K |
| 82150 | <1% | 347 | $1K | |
| 84439 | <1% | 187 | $1K | |
| 83540 | <1% | 171 | $1K | |
| 83690 | <1% | 210 | $984.65 | |
| 81015 | <1% | 323 | $861.01 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 32 | $837.32 |
| 80183 | <1% | 85 | $775.97 | |
| 0002A | <1% | 38 | $741.60 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 69 | $681.57 |
| 85730 | <1% | 221 | $595.51 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 78 | $543.91 |
| 81003 | <1% | 215 | $449.68 | |
| 85610 | <1% | 221 | $414.99 | |
| 0001A | <1% | 39 | $302.38 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $288.96 |
| 84100 | <1% | 92 | $231.76 | |
| 87070 | <1% | 18 | $210.96 | |
| 82947 | <1% | 80 | $186.16 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $134.83 |
| 85379 | <1% | 22 | $90.48 | |
| 86701 | <1% | 12 | $88.90 | |
| 84450 | <1% | 13 | $62.16 | |
| 80076 | <1% | 12 | $57.19 | |
| 85652 | <1% | 31 | $54.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 86 | $0.00 |
| 00000 | 0% | 13 | $0.00 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 13,455 | $0.00 |
| 91300 | 0% | 47 | $0.00 | |
| 87631 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGREER, MILDRED (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Hospital Service District No1a of the Parish of Richland State of LA | Delhi, LA | $9.23M |
| Hospital Service District No 1-A of the Parish of Richland State of LA | Delhi, LA | $9.00M |
| Hospital Service District No 1A of the Parish of Richland State of LA | Delhi, LA | $1.82M |
| Hospital Service District No1a of the Parish of Richland State of LA | Delhi, LA | $1.20M |
| Hospital Service District No 1-A of the Parish of Richland State of LA | Delhi, LA | $431K |
| Hospital Service District No 1A of the Parish of Richland State of LA | Delhi, LA | $238K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.